对比FDA和CFDA批准的抗癌药物列表

2020-02-28 其他范文 下载本文

对比FDA和CFDA批准的抗癌药物列表由刀豆文库小编整理,希望给你工作、学习、生活带来方便”。

 对比FDA和CFDA批准的抗癌药物列表。

 发现事实。下面的都是FDA批准的靶点药,而有中文名称的是CFDA允许在国内销售的。

可以说,国内病人基本享受不到自从05年以来的绝大多数抗癌研究成果。为父亲大人学习相关知识。

AgentTarget(s)FDA-approved indication(s)CFDA approved Ado-trastuzumab emtansine HER2(ERBB2/neu)(Kadcyla)EGFR(HER1/ERBB1), HER2 Afatinib(Gilotrif)(ERBB2/neu)Aldesleukin(Proleukin)

Alemtuzumab(Campath)Axitinib(Inlyta)Belimumab(Benlysta)Belinostat(Beleodaq)Bevacizumab(Avastin)

Bortezomib(Velcade)[1] |

2014-12-30 11:28jastee

CD52 KIT, PDGFRβ, VEGFR1/2/3 BAFF HDAC VEGF ligand

Proteasomesubstitution(L858R)mutations)Renal cell carcinoma Melanoma

B-cell chronic lymphocytic leukemia Renal cell carcinoma Lupus erythematosus Peripheral T-cell lymphoma Cervical cancer

注射液

Colorectal cancer Fallopian tube cancer Glioblastoma

Non-small cell lung cancer Ovarian cancer Peritoneal cancer Renal cell carcinoma Multiple myeloma

佐米

注射用硼替

贝伐珠单抗

Non-small cell lung cancer(with EGFR exon 19 deletions or exon

Breast cancer(HER2+)

Bosutinib(Bosulif)Brentuximab vedotin

ABL CD30

Mantle cell lymphoma

Chronic myelogenous leukemia(Philadelphia chromosome positive)Hodgkin lymphoma

Anaplastic large cell lymphoma Medullary thyroid cancer

(Adcetris)

Cabozantinib(Cometriq)VEGFR2 Canakinumab(Ilaris)

Carfilzomib(Kyprolis)IL-1β

Proteasome

Juvenile idiopathic arthritis

Cryopyrin-aociated periodic syndromes Multiple myeloma

FLT3, KIT, MET, RET, Ceritinib(Zykadia)Cetuximab(Erbitux)

Crizotinib(Xalkori)Dabrafenib(Tafinlar)Dasatinib(Sprycel)

Denosumab(Xgeva)Erlotinib(Tarceva)

Everolimus(Afinitor)

Gefitinib(Irea)Ibritumomab tiuxetan ALK EGFR(HER1/ERBB1)

ALK, MET BRAF ABL

RANKL EGFR(HER1/ERBB1)

mTOR

Non-small cell lung cancer(with ALK fusion)Colorectal cancer(KRAS wild type)

西妥昔单抗注射液

Squamous cell cancer of the head and neck Non-small cell lung cancer(with ALK fusion)Melanoma(with BRAF V600 mutation)

Chronic myelogenous leukemia(Philadelphia chromosome positive)Acute lymphoblastic leukemia(Philadelphia chromosome positive)Giant cell tumor of the bone Non-small cell lung cancer

克唑替尼胶囊

达沙替尼片

盐酸厄洛替尼片

Pancreatic cancer

Pancreatic neuroendocrine tumor Renal cell carcinoma

Nonresectable subependymal giant cell astrocytoma aociated with

依维莫司片

tuberous sclerosis

EGFR(HER1/ERBB1)

(limited approval)CD20(Zevalin)Ibrutinib(Imbruvica)|

2014-12-30 11:29jastee BTK

Mantle cell lymphoma

Non-Hodgkin's lymphoma

Breast cancer(HR+, HER2-)

Non-small cell lung cancer with known prior benefit from gefitinib

吉非替尼片

Idelalisib(Zydelig)

Imatinib(Gleevec)

Ipilimumab(Yervoy)Lapatinib(Tykerb)

PI3Kδ

KIT, PDGFR, ABL

Chronic lymphocytic leukemia Chronic lymphocytic leukemia

Follicular B-cell non-Hodgkin lymphoma Small lymphocytic lymphoma GI stromal tumor(KIT+)Dermatofibrosarcoma protuberans

Multiple hematologic malignancies including Philadelphia

chromosome-positive ALL and CML CTLA-4 HER2(ERBB2/neu), EGFR

Breast cancer(HER2+)(HER1/ERBB1)

Chronic myelogenous leukemia(Philadelphia chromosome Nilotinib(Tasigna)Obinutuzumab(Gazyva)Ofatumumab(Arzerra, CD20 HuMax-CD20)Panitumumab(Vectibix)Pazopanib(Votrient)EGFR(HER1/ERBB1)VEGFR, PDGFR, KIT

Colorectal cancer(KRAS wild type)Renal cell carcinoma Melanoma

Breast cancer(HER2+)

Chronic lymphocytic leukemia

ABL

positive)CD20

Chronic lymphocytic leukemia

尼洛替尼胶

Melanoma

Pembrolizumab(Keytruda)PD-1 Pertuzumab(Perjeta)HER2(ERBB2/neu)Ponatinib(Iclusig)

Ramucirumab(Cyramza)ABL, FGFR1-3, FLT3, VEGFR2 Chronic myelogenous leukemia

VEGFR2

Acute lymphoblastic leukemia(Philadelphia chromosome positive)

Gastric cancer or Gastroesophageal junction(GEJ)adenocarcinoma

Regorafenib(Stivarga)

Rituximab(Rituxan, Mabthera)

Romidepsin(Istodax)

Ruxolitinib(Jakafi)Siltuximab(Sylvant)Sipuleucel-T(Provenge)Sorafenib(Nexavar)

Temsirolimus(Torisel)Tocilizumab(Actemra)

Tofacitinib(Xeljanz)Tositumomab(Bexxar)Trametinib(Mekinist)Trastuzumab(Herceptin)

Vandetanib(Caprelsa)Vemurafenib(Zelboraf)Vismodegib(Erivedge)Vorinostat(Zolinza)Ziv-aflibercept(Zaltrap)KIT, PDGFRβ, RAF, RET, VEGFR1/2/3

CD20

HDAC

JAK1/2 IL-6

VEGFR, PDGFR, KIT, RAF

mTOR IL-6R

JAK3 CD20 MEK HER2(ERBB2/neu)

EGFR(HER1/ERBB1), RET, VEGFR2 BRAF PTCH, Smoothened HDAC PIGF, VEGFA/B

Colorectal cancer

Gastrointestinal stromal tumors Non-Hodgkin’s lymphoma

Chronic lymphocytic leukemia Rheumatoid arthritis

Granulomatosis with polyangiitis Cutaneous T-cell lymphoma Peripheral T-cell lymphoma Myelofibrosis

Multicentric Castleman's disease Prostate cancer

Hepatocellular carcinoma

Renal cell carcinoma Thyroid carcinoma Renal cell carcinoma Rheumatoid arthritis

Juvenile idiopathic arthritis Rheumatoid arthritis Non-Hodgkin's lymphoma

Melanoma(with BRAF V600 mutation)Breast cancer(HER2+)

Gastric cancer(HER2+)Medullary thyroid cancer

Melanoma(with BRAF V600 mutation)Basal cell carcinoma Cutaneous T-cell lymphoma Colorectal cancer

.利妥昔单抗注射液

甲苯磺酸索拉非尼片

托珠单抗注射液

注射用曲妥珠单抗(

《对比FDA和CFDA批准的抗癌药物列表.docx》
将本文的Word文档下载,方便收藏和打印
推荐度:
对比FDA和CFDA批准的抗癌药物列表
点击下载文档
相关专题
[其他范文]相关推荐
    [其他范文]热门文章
      下载全文